• LAST PRICE
    4.6050
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    4.5100/ 3
  • Ask / Lots
    5.2000/ 10
  • Open / Previous Close
    0.0000 / 4.6050
  • Day Range
    ---
  • 52 Week Range
    Low 1.8650
    High 40.5800
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 4.71
TimeVolumeVTYX
09:32 ET35664.79
09:34 ET2104.8102
09:36 ET32264.72
09:38 ET2504.71
09:39 ET2004.71
09:41 ET13004.74
09:43 ET11454.75
09:45 ET16004.7515
09:50 ET21194.74
09:56 ET20954.7216
10:01 ET10004.7
10:03 ET64024.68
10:06 ET49084.65
10:08 ET14004.66
10:10 ET28784.67
10:12 ET15004.684
10:14 ET10124.6817
10:15 ET1004.7
10:17 ET14034.69
10:19 ET5004.69
10:21 ET37004.69
10:24 ET80834.65
10:26 ET12594.66
10:28 ET9004.66
10:30 ET6994.65
10:32 ET1004.65
10:33 ET3004.65
10:35 ET1004.635
10:37 ET2004.64
10:39 ET11004.622
10:42 ET34684.66
10:44 ET1004.66
10:46 ET14004.66
10:48 ET1004.65
10:51 ET11634.69
10:53 ET7714.72
10:55 ET15004.73
10:57 ET1004.73
11:00 ET1004.72
11:02 ET3004.74
11:04 ET33024.7177
11:06 ET2004.71
11:09 ET3004.71
11:11 ET2004.71
11:13 ET14374.6999
11:15 ET8554.7
11:18 ET2004.7
11:20 ET2004.7
11:22 ET1004.7
11:27 ET22004.6903
11:29 ET20524.7
11:33 ET16004.68
11:36 ET2004.68
11:38 ET4244.67
11:40 ET1004.67
11:42 ET2004.67
11:44 ET2004.67
11:45 ET3004.68
11:47 ET2004.67
11:51 ET2004.67
11:56 ET1004.66
12:00 ET1004.66
12:02 ET4004.66
12:07 ET1004.66
12:09 ET12864.63
12:12 ET5004.6399
12:14 ET4004.63
12:16 ET6004.63
12:18 ET2004.62
12:20 ET3254.6284
12:21 ET15004.635
12:25 ET2004.64
12:27 ET3004.63
12:30 ET81354.66
12:32 ET3004.65
12:34 ET5004.65
12:36 ET27004.65
12:38 ET1004.64
12:39 ET8004.64
12:41 ET11694.66
12:43 ET6984.67
12:45 ET4004.66
12:48 ET2004.65
12:50 ET6614.66
12:52 ET1004.66
12:54 ET1004.66
12:56 ET1004.66
12:59 ET36594.66
01:01 ET3004.66
01:03 ET12004.65
01:06 ET3004.65
01:08 ET3004.6512
01:10 ET4004.64
01:14 ET2004.63
01:15 ET10984.64
01:17 ET5494.64
01:19 ET4004.64
01:21 ET3004.63
01:24 ET2004.63
01:26 ET4004.63
01:28 ET1004.62
01:30 ET1004.62
01:32 ET11004.62
01:35 ET12004.6246
01:37 ET1004.62
01:39 ET2004.61
01:42 ET15214.62
01:44 ET6504.62
01:48 ET1004.6275
01:50 ET3004.61
01:51 ET19424.605
02:00 ET1004.605
02:04 ET1004.605
02:06 ET2394.61
02:08 ET16814.59
02:09 ET4004.6
02:11 ET6314.5817
02:13 ET4004.59
02:15 ET29434.61
02:18 ET10004.62
02:20 ET3004.61
02:22 ET2004.6
02:26 ET4004.6
02:27 ET10834.58
02:29 ET11314.59
02:36 ET2004.58
02:38 ET10004.59
02:40 ET1004.58
02:42 ET33004.58
02:44 ET5014.58
02:45 ET2004.58
02:47 ET26984.59
02:49 ET2004.58
02:54 ET28794.58
02:56 ET3004.57
02:58 ET1004.585
03:00 ET3654.58
03:02 ET4004.57
03:05 ET1004.57
03:07 ET34184.595
03:09 ET1004.6
03:12 ET1004.595
03:14 ET2974.595
03:16 ET5134.59
03:20 ET1004.58
03:21 ET25164.595
03:23 ET4004.595
03:25 ET1004.59
03:27 ET14444.58
03:30 ET2004.58
03:32 ET9164.58
03:34 ET41964.59
03:38 ET2004.595
03:39 ET2004.595
03:41 ET6644.59
03:43 ET5004.59
03:45 ET36444.625
03:48 ET9024.62
03:50 ET20094.61
03:52 ET58404.59
03:54 ET13384.59
03:56 ET40234.6
03:57 ET95614.595
03:59 ET82304.605
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVTYX
Ventyx Biosciences Inc
324.6M
-1.4x
---
United StatesAVXL
Anavex Life Sciences Corp
325.0M
-7.2x
---
United StatesAVIR
Atea Pharmaceuticals Inc
331.8M
-2.4x
---
United StatesQTTB
Q32 Bio Inc
324.4M
-0.8x
---
United StatesATAI
ATAI Life Sciences NV
340.4M
-7.2x
---
United StatesGUTS
Fractyl Health Inc
304.5M
-3.2x
---
As of 2024-05-08

Company Information

Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of small molecule product candidates to address a range of inflammatory diseases with unmet need. The Company’s pipeline includes VTX002 (S1P1R Modulator), VTX958 (TYK2 Inhibitor), and VTX2735 and VTX3232 (NLRP3 Inhibitor Portfolio). VTX002 is a sphingosine 1 phosphate receptor (S1P1R) modulator in Phase II development for patients with moderately to severely active ulcerative colitis (UC). VTX958 is an oral, selective clinical-stage inhibitor of tyrosine kinase type 2 (TYK2), an intracellular signaling kinase in the Janus kinase (JAK) family that regulates chronic inflammation in immune-mediated diseases. Its third product candidate, VTX2735, is a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor. In addition to VTX2735, it is also developing VTX3232, its lead CNS-penetrant NLRP3 inhibitor in Phase 1 development.

Contact Information

Headquarters
12790 El Camino Real, Suite 200SAN DIEGO, CA, United States 92130
Phone
858-945-2393
Fax
302-655-5049

Executives

Executive Chairperson of the Board
Sheila Gujrathi
President, Chief Executive Officer, Founder, Director
Raju Mohan
Chief Financial Officer
Martin Auster
Chief Scientific Officer
John Nuss
Independent Director
Onaiza Cadoret-manier

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$324.6M
Revenue (TTM)
$0.00
Shares Outstanding
70.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-3.29
Book Value
$4.12
P/E Ratio
-1.4x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.